Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No doubt in my mind

Totally agree with that. A PR along with a Q is usually SOP for most, if not all, companies. I would expect something from him today,obviously minus any details of the recent agreements, but something...anything ...to communicate to the investment community of where we are headed.

Without direction from above we will drift around with no clear course for our PPS to follow.

Share
New Message
Please login to post a reply